Sequent Scientific has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the re-appointment of Kamal Sharma (DIN: 00209430) and Milind Sarwate (DIN: 00109854) as Non-Executive Independent Director of the Company for a second term of five consecutive years from August 25, 2025, to August 24, 2030, subject to approval of the shareholders. The details under Regulation 30 of the Listing Regulations read along with SEBI circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and the SEBI circular no. SEBI/HO/CFD/CFD-PoD 2/CIR/P/2024/185 dated December 31, 2024, are enclosed as ‘Annexure A’. The aforesaid information is also being made available on the website of the Company at: https://sequent.in/investor-relation/.
The above information is a part of company’s filings submitted to BSE.
